National Institutes of Health (NIH) scientists have developed a new surgical technique for implanting multiple tissue grafts in the eye’s retina. The findings in

Atsena Therapeutics has announced positive clinical results from the LIGHTHOUSE study, evaluating subretinal injection of a novel gene therapy to treat X-linked retinoschisis (XLRS).

A research initiative between RMIT University and digital health company DDM Health will look to the potential of artificial intelligence (AI) voice analysis technology

The “first and only” continuous delivery treatment for diabetic retinopathy (DR) has been approved by the United States Food and Drug Administration (US FDA).